Cancer drug effectiveness substantially advanced
Researchers have shown that a peptide (a chain of amino acids) called iRGD helps co-administered drugs penetrate deeply into tumor tissue. The peptide has been shown to substantially increase treatment efficacy against human breast, prostate and pancreatic cancers in mice, achieving the same therapeutic effect as a normal dose with one-third as much of the drug. In a transformative paper …

Read more on PhysOrg

Related posts

• Advanced Breast Cancer Diagnosis
• Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
• Research Reveals Cancer Drug Effectiveness Substantially Advanced
• when Neoadjuvant Chemotherapy is used in breast cancer treatment in advanced stages only or early or both?
• Racial Disparities Persist In Diagnosis Of Advanced Breast, Colon Cancer
• Zoledronic Acid Reduces Spread Of Cancer Cells In Women Undergoing Chemotherapy For Locally Advanced Breast Cancer
• James Cook University Hospital Introduces Advanced TomoTherapy(R) Radiation Therapy Treatments
• Peregrine to Present Lung, Advanced Breast, and Brain Cancer Clinical Data at 2010 ASCO Annual Meeting
• Genentech Submits Supplemental Application to FDA for Herceptin in Advanced HER2-Positive Stomach Cancer
• Kylie Minogue strips for breast cancer campaign